David Herranz

1 ta ish

GMV Innovating Solutions (Spain)

1. First-in-human trial of atrial fibrillation ablation using real-time tissue optical assessment to predict pulsed field lesion durability

   Raphaël P. Martins, Giorgi Papiashvili, Askar Sabirov +4

   MaqolaOAOchiq kirishAtrial Fibrillation Management and OutcomesEP Europace20250 iqtibos

   ABIABI:AkademIndex/2025.article.000551